SS-31 Complete Research Guide 2026 — Mitochondrial-Targeted Peptide & Cardiolipin Mechanism

SS-31 belongs to a class of small peptides engineered to selectively concentrate in mitochondria, where research has focused on its interaction with cardiolipin — a phospholipid unique to the inner mitochondrial membrane and essential to the electron transport chain.

Selective Mitochondrial Targeting

Unlike many compounds studied for general antioxidant effects, SS-31's research distinction is its selective accumulation within mitochondria specifically, driven by its alternating cationic and aromatic residue structure that allows it to cross mitochondrial membranes preferentially.

Cardiolipin Stabilization Research

Cardiolipin is prone to oxidative damage and structural disruption with aging and metabolic stress. Research suggests SS-31 binds cardiolipin and helps stabilize its structure, which in turn is studied for downstream effects on electron transport chain efficiency.

Cellular Energy and Aging Research

Because mitochondrial dysfunction is a recurring theme across aging biology research, SS-31 has been studied alongside other mitochondrial-support compounds like MOTS-c and NAD+ precursors, though its mechanism — direct cardiolipin interaction — is distinct from either.

Research Considerations

SS-31 is typically studied via subcutaneous administration in research models, with stability considerations similar to other small peptides — proper reconstitution and cold storage are standard research handling practice.

Research Use Only. DisclaimerFor laboratory and research use only. Not for human consumption. This content is educational and does not constitute medical advice.